Evidence map›Paper›PMID 37457800›Full record

ArticleInternational journal of nanomedicine2023

Fabrication of a Novel Au Star@AgAu Yolk-Shell Nanostructure for Ovarian Cancer Early Diagnosis and Targeted Therapy.

Ting Lan, Yang Zhao, Yu Du, Chunyi Ma, Rui Wang, Qianlei Zhang, Shanshan Wang, Wenxian Wei, Honghua Yuan, Qingli Huang

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Ting Lan *Medical Technology School of Xuzhou Medical University, Xuzhou City, Jiangsu, 221000, People's Republic of China.
Yang Zhao *Medical Technology School of Xuzhou Medical University, Xuzhou City, Jiangsu, 221000, People's Republic of China.
Yu Du *Medical Technology School of Xuzhou Medical University, Xuzhou City, Jiangsu, 221000, People's Republic of China.ORCID 0000-0003-4617-6178
Chunyi MaMedical Technology School of Xuzhou Medical University, Xuzhou City, Jiangsu, 221000, People's Republic of China.
Rui WangMedical Technology School of Xuzhou Medical University, Xuzhou City, Jiangsu, 221000, People's Republic of China.
Qianlei ZhangMedical Technology School of Xuzhou Medical University, Xuzhou City, Jiangsu, 221000, People's Republic of China.
Shanshan WangMedical Technology School of Xuzhou Medical University, Xuzhou City, Jiangsu, 221000, People's Republic of China.
Wenxian WeiTesting Center, Yangzhou University, Yangzhou City, Jiangsu, 225009, People's Republic of China.
Honghua YuanPublic Experimental Research Center of Xuzhou Medical University, Xuzhou City, Jiangsu, 221004, People's Republic of China.ORCID 0009-0008-7582-916X
Qingli HuangMedical Technology School of Xuzhou Medical University, Xuzhou City, Jiangsu, 221000, People's Republic of China.ORCID 0000-0001-6706-6053
Xuzhou Medical College · CNYangzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: A novel CYPA-targeted, SiO Methods: Diverse spectroscopic and microscopic methods were utilized to investigate the pattern of the yolk-shell nanostructure. In addition, in vitro and in vivo experiments were carried out. Results: It can be found that the ratio of HAuCl Conclusion: This work holds promise to offer a new method for the detection and therapy of ovarian cancer in the early stage.

Indexed as

NanostructuresOvarian NeoplasmsEarly Detection of CancerFemaleGoldHumansSilicon DioxideSpectrum Analysis, RamanGoldSilicon Dioxidecancer targeted therapyearly diagnosissurface-enhanced Raman scatteringyolk-shell nanostructure

Identifiers

PMID37457800
PMCPMC10348339
OpenAlexW4383723157

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.